Sia Viborg Lindskrog

8PUBLICATIONS
48CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 25, 2026
Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes.

Laura Andersen, Sia V Lindskrog, Iver Nordentoft

|Nov 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types.

Ludvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting

|Jul 10, 2024
Towards circulating tumor DNA-guided treatment of muscle-invasive bladder cancer.

Sia Viborg Lindskrog, Lars Dyrskjøt

|Oct 02, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.

Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft

|Feb 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer.

Emil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder

|Apr 05, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.

Ann Taber, Emil Christensen, Philippe Lamy

Pageof 2

Frequent Collaborators

8 joint publications

Lars Dyrskjøt

7 joint publications

Iver Nordentoft

6 joint publications

Philippe Lamy

5 joint publications

Emil Christensen